Literature DB >> 9779522

Nasal resistance in snorers with or without sleep apnea: effect of posture and nasal ventilation with continuous positive airway pressure.

P Desfonds1, C Planès, C Fuhrman, A Foucher, B Raffestin.   

Abstract

We investigated the effects of posture and nasal ventilation with continuous airway pressure (CPAP) on nasal resistance in snorers with or without obstructive sleep apnea (OSA). Posterior rhinomanometry was performed in 70 snorers referred for polysomnography and in 11 nonsnoring volunteers, (1) in the seated posture; (2) and (3) after 10 minutes in the supine position, before and after inhalation of oxymetazoline; and (4) 10 minutes after return to the seated position. The effect of CPAP on posterior rhinomanometry was also examined in the nonsnorers and in 12 of the snorers. Changing from the seated to the supine position resulted in an increase in resistance in snorers and nonsnorers (resistance supine 182 +/- 10.9% and 128 +/- 6.7% respectively of seated value, p < 0.05). After oxymetazoline instillation, resistance in the supine position decreased but remained higher in snorers than baseline value in the seated position. Effects of posture and oxymetazoline were similar in snorers with or without sleep apnea. During nasal ventilation with CPAP, resistance was 30 +/- 3.8 and 45 +/- 4.4% of value before CPAP in snorers and nonsnorers, respectively (p < 0.05). These effects of posture and CPAP were also observed when resistance was measured with anterior rhinomanometry. In conclusion, nasal resistance measured with posterior rhinomanometry in the supine position is not predictive for OSA. Nasal ventilation with CPAP resulted in an acute and marked decrease in nasal resistance.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9779522     DOI: 10.1093/sleep/21.6.625

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  8 in total

1.  Continuous positive airway pressure intolerance associated with elevated nasal resistance is possible mechanism of complex sleep apnea syndrome.

Authors:  Chie Nakazaki; Akiko Noda; Yoshinari Yasuda; Seiichi Nakata; Yasuo Koike; Fumihiko Yasuma; Toyoaki Murohara; Tsutomu Nakashima
Journal:  Sleep Breath       Date:  2011-08-10       Impact factor: 2.816

2.  Upper-airway collapsibility: measurements and sleep effects.

Authors:  A Malhotra; G Pillar; R Fogel; J Beauregard; J Edwards; D P White
Journal:  Chest       Date:  2001-07       Impact factor: 9.410

Review 3.  Nasal function and CPAP use in patients with obstructive sleep apnoea: a systematic review.

Authors:  Marina Brimioulle; Konstantinos Chaidas
Journal:  Sleep Breath       Date:  2021-09-02       Impact factor: 2.655

Review 4.  Impact of impaired nasal breathing on sleep-disordered breathing.

Authors:  Thomas Verse; Wolfgang Pirsig
Journal:  Sleep Breath       Date:  2003-06       Impact factor: 2.816

5.  Predictive role of nasal functionality tests in the evaluation of patients before nocturnal polysomnographic recording.

Authors:  F M Passali; L Bellussi; S Mazzone; D Passali
Journal:  Acta Otorhinolaryngol Ital       Date:  2011-04       Impact factor: 2.124

6.  Effects of nasal dilator strips on subjective measures of sleep in subjects with chronic nocturnal nasal congestion: a randomized, placebo-controlled trial.

Authors:  Eric J Schenkel; Renee Ciesla; Gilbert Marava Shanga
Journal:  Allergy Asthma Clin Immunol       Date:  2018-08-27       Impact factor: 3.406

7.  Objective and Subjective Effects of a Prototype Nasal Dilator Strip on Sleep in Subjects with Chronic Nocturnal Nasal Congestion.

Authors:  John R Wheatley; Terence C Amis; Sharon A Lee; Renee Ciesla; Gilbert Shanga
Journal:  Adv Ther       Date:  2019-05-22       Impact factor: 3.845

8.  Epidemiological analysis of structural alterations of the nasal cavity associated with obstructive sleep apnea syndrome (OSA).

Authors:  Levon Mekhitarian Neto; Antonio Sérgio Fava; Hugo Canhete Lopes; Aldo Stamm
Journal:  Braz J Otorhinolaryngol       Date:  2005-12-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.